Company: DNLI
Filing Date: 2025-04-17
Form Type: DEF 14A
Source: 0001714899-25-000087
Chunk: 82

Company: Denali Therapeutics Inc.
Filing Date: 2025-04-17
Form: DEF 14A
Chunk 82
---
 will vest within such date.

(16) Consists of (a) 1,880,539 shares held of record by Dr. Tessier-Lavigne, (b) 78,848 shares held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1 (c) 79,173 shares held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, (d) 78,848 shares held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3 and (e) 59,875 shares subject to options exercisable and RSUs lapsing within 60 days of March 31, 2025, all of which will vest with such date.

(17) Consists of (a) 18,680 shares held of record by Ms. Thornberry and (b) 38,143 shares subject to options exercisable and RSUs lapsing within 60 days of March 31, 2025, all of which will vest with such date.

(18) Consists of (a) 326,302 shares held of record by 667, L.P., and (b) 3,405,393 shares held of record by Baker Brothers Life Sciences, L.P. (collectively, the “Baker Funds”), and (c) prefunded warrants to purchase an aggregate of 3,699,790 shares of our common stock held by the Baker Funds, which may be exercised within 60 days of March 31, 2025. This amount excludes prefunded warrants to purchase an aggregate of 22,346,275 shares of our common stock held by the Baker Funds, the exercise of which is currently limited pursuant to an ownership limitation, and therefore the shares of our capital stock issuable upon exercise of such prefunded warrants are not deemed to be beneficially owned within 60 days of March 31, 2025. Julian C. Baker is the managing member of Baker Bros. Advisors (GP), LLC, the sole general partner of Baker Bros. Advisors LP, the investment advisor to the Baker Funds with sole voting and investment power with respect to the securities held by the Baker Funds, and therefore Mr. Baker may be deemed to beneficially own shares of our common stock beneficially owned by Baker Bros. Advisors LP and its affiliated funds. Pursuant to the policies of Baker Bros. Advisors LP, Mr. Baker does not have a right to any of Company’s securities